Cyted Health, a leading gastrointestinal molecular diagnostics company, today announces the enrollment of the first patient in the DETECT-ME clinical validation study (NCT06803927). The study ...

Esophageal cancer affects the esophagus lining, causing swallowing difficulty and chest pain. Learn what symptoms to look for ...

If this story sounds extraordinary, it’s not without precedent.

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that ...

Study confirms clinical utility of EsoGuard as a non-invasive triage tool to significantly increase positive yield of invasive upper endoscopy The ENVET-BE study reviewed real-world data from a cohort ...

Q4 2024 Earnings Call Transcript March 24, 2025 Lucid Diagnostics Inc. misses on earnings expectations. Reported EPS is ...

Lucid Diagnostics Inc.�(Nasdaq: LUCD)�("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, a ...

Background: It is currently recommended that all patients with liver cirrhosis undergo upper gastrointestinal endoscopy (UGIE) to identify those who have large esophageal varices (LEVx ...

Acid reflux, also known as gastroesophageal reflux disease (GERD), is a common condition in pets, particularly dogs and cats.

Highlights society guidelines recommending non-endoscopic biomarker testing, such as Lucid's EsoGuard Esophageal DNA Test, as an acceptable alternative to endoscopy "This update is an important ...

Highlights society guidelines recommending non-endoscopic biomarker testing, such as Lucid’s EsoGuard Esophageal DNA Test, as an acceptable alternative to endoscopy “This update is an important step ...